The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines.

IF 1.2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Journal of Cardiovascular and Thoracic Research Pub Date : 2023-01-01 DOI:10.34172/jcvtr.2023.31585
Mehrzad Mirshekari, Nooshin Shirzad, Mahboobeh Hemmatabadi, Soha Namazi
{"title":"The approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines.","authors":"Mehrzad Mirshekari,&nbsp;Nooshin Shirzad,&nbsp;Mahboobeh Hemmatabadi,&nbsp;Soha Namazi","doi":"10.34172/jcvtr.2023.31585","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Introduction:</i></b> Optimal treatment of dyslipidemia is a top priority in the prevention of cardiovascular diseases. For this purpose, clinicians in Iran usually refer to four current international guidelines. The aim of this study was to assess the approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines. <b><i>Methods:</i></b> A structured questionnaire was prepared. Questions (n=24) included the demographics (n=7), dyslipidemia references (n=3), dyslipidemia general knowledge of respondents (n=10), and questions (n=4) designed based on the difference among the latest version of guidelines participants stated they use in their practice. After validity conformation, the questionnaire was distributed to 120 clinical pharmacists, electronically from May to August 2021. <b><i>Results:</i></b> Response rate was 77.5% (n=93). The majority of participants (80.6%, n=75) claimed to have used the 2018 ACC/AHA guideline. The Median (interquartile range [IQR]) score of the general knowledge questions was 5.0 (2.0) out of 10. The Median (IQR) score of questions designed based on the difference among guidelines was calculated 3(1) out of 4. There was no significant (<i>P</i>=0.25) difference in score among participants according to their guideline selection. Moreover, the gender and length of experience as a clinical pharmacist had no significant (<i>P</i>>0.05) effect on the score of participants. <b><i>Conclusion:</i></b> In this study, Iranian clinical pharmacists answered half of the dyslipidemia general knowledge questions correctly. Also, Participants were up-to-date on 75% of the questions designed based on the latest version of the guideline they had been using in their practice.</p>","PeriodicalId":15207,"journal":{"name":"Journal of Cardiovascular and Thoracic Research","volume":"15 1","pages":"30-36"},"PeriodicalIF":1.2000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278195/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cardiovascular and Thoracic Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.34172/jcvtr.2023.31585","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Optimal treatment of dyslipidemia is a top priority in the prevention of cardiovascular diseases. For this purpose, clinicians in Iran usually refer to four current international guidelines. The aim of this study was to assess the approach of Iranian clinical pharmacists in the treatment of dyslipidemia based on international guidelines. Methods: A structured questionnaire was prepared. Questions (n=24) included the demographics (n=7), dyslipidemia references (n=3), dyslipidemia general knowledge of respondents (n=10), and questions (n=4) designed based on the difference among the latest version of guidelines participants stated they use in their practice. After validity conformation, the questionnaire was distributed to 120 clinical pharmacists, electronically from May to August 2021. Results: Response rate was 77.5% (n=93). The majority of participants (80.6%, n=75) claimed to have used the 2018 ACC/AHA guideline. The Median (interquartile range [IQR]) score of the general knowledge questions was 5.0 (2.0) out of 10. The Median (IQR) score of questions designed based on the difference among guidelines was calculated 3(1) out of 4. There was no significant (P=0.25) difference in score among participants according to their guideline selection. Moreover, the gender and length of experience as a clinical pharmacist had no significant (P>0.05) effect on the score of participants. Conclusion: In this study, Iranian clinical pharmacists answered half of the dyslipidemia general knowledge questions correctly. Also, Participants were up-to-date on 75% of the questions designed based on the latest version of the guideline they had been using in their practice.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
伊朗临床药师根据国际指南治疗血脂异常的方法。
导读:血脂异常的最佳治疗是预防心血管疾病的重中之重。为此目的,伊朗的临床医生通常参考四项现行国际指南。本研究的目的是根据国际指南评估伊朗临床药师治疗血脂异常的方法。方法:编制结构化问卷。问题(n=24)包括人口统计学(n=7)、血脂异常参考文献(n=3)、受访者的血脂异常常识(n=10),以及根据参与者在实践中使用的最新版本指南之间的差异设计的问题(n=4)。经效度确认后,于2021年5月至8月以电子方式向120名临床药师发放问卷。结果:有效率为77.5% (n=93)。大多数参与者(80.6%,n=75)声称使用了2018年ACC/AHA指南。一般知识问题的中位数(四分位范围[IQR])得分为5.0(2.0)。根据指南之间的差异设计的问题的中位数(IQR)分数计算为3(1)/ 4。根据不同的指南选择,受试者的得分无显著差异(P=0.25)。此外,性别和临床药师经验长短对参与者的得分无显著影响(P>0.05)。结论:在本研究中,伊朗临床药师正确回答了一半的血脂异常常识问题。此外,参与者根据他们在实践中使用的指南的最新版本设计的问题中有75%是最新的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Journal of Cardiovascular and Thoracic Research
Journal of Cardiovascular and Thoracic Research CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
2.00
自引率
0.00%
发文量
22
审稿时长
7 weeks
期刊最新文献
Evaluating the relationship between lactate levels during coronary artery bypass graft surgery and postoperative renal dysfunction. Genetic association of FTO gene polymorphisms with obesity and its related phenotypes: A case-control study. Risk estimation of cardiovascular diseases using the World Health Organization/International Society of Hypertension risk prediction charts in the Azar cohort population: Cross-sectional study. The role of probiotics on microvascular complications of type-2 diabetes: Nephropathy and retinopathy. Walking or breathing: comparing the 6-minute walking distance test to the pulmonary function test for lung resection candidates.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1